614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study
Lee, Keun-Wook, Park, John, Kim, Seung-Tae, Sriuranpong, Virote, Rha, Sun Young, Yoo, Changhoon, Kim, Sehyun, Keam, Bhumsuk, Sabanathan, Dhanusha, Park, Joon Oh, Parinyanitikul, Napa, Kim, Min Hwan, Kim, Kyu Pyo, Ock, Chan-Young, Yoon, Jaebong, Lim, Hyelim, Lee, Sangheon, Jang, Wooick, Oh, Do-Youn
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Abstract 3367: Preclinical characterization of YBL-006, a fully human anti-PD-1 antibody being ready for clinical studies
Yoon, Jaebong, Lee, Hyunmi, Jeon, Eunyoung, Lee, Jinsil, Shim, Eunyoung, Lee, Hyunju, Lee, Eunjin, Cho, Younggyu, Park, Bumchan, Lee, Hanseung, Park, Youngwoo
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Safety and efficacy of YBL-006, an anti-PD-1 monoclonal antibody in advanced solid tumors: A phase I study
Oh, Do-Youn, Park, John J., Lee, Keun Wook, Kim, Seung Tae, Sriuranpong, Virote, Rha, Sun Young, Yoo, Changhoon, Keam, Bhumsuk, Sabanathan, Dhanusha, Kim, Se Hyun, Park, Joon Oh, Parinyanitikul, Napa, Kim, Min Hwan, Kim, Kyu-Pyo, Kim, Myungsuk, Yoon, Jaebong, Lee, Han Seung, Ock, Chan-Young
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Interim analysis of first-in-human phase 1 study to assess safety and efficacy of YBL-006, an anti-PD-1 antibody in advanced solid tumor with exploratory biomarker analysis of tumor mutational burden and artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes
Park, John J., Lee, Keun Wook, Oh, Do-Youn, Sabanathan, Dhanusha, Kim, Se Hyun, Kim, Tae Min, Kim, Myungsuk, Yoon, Jaebong, Lee, Hyunmi, Kim, Boram, Ko, Yunjung, Jeon, Eunyoung, Cheon, Seonghye, Shim, Eunyoung, Park, Bum-Chan, Lee, Han Seung, Park, Seongyeol, Paeng, Kyunghyun, Ock, Chan-Young
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
MULTI SPECIFIC FUSION PROTEIN AND USE THEREOF
RYU JAENAM, YANG SO YOUNG, JANG SEIL, LEE EUNJIN, KIMYOUNG, JANG CHANGHO, LEE JAEMIN, SONG YOUNGJA, BAEK GISUN, KIM HYE NAN, LEE HYUN MI, SONG JAEHO, YOON JAEBONG, KIM YEUNG CHUL, PARK YOUNG WOO, BAK JEONGHYEON, MOK JINKEOL, PARK BUM CHAN
Year of Publication 21.04.2021
Get full text
Year of Publication 21.04.2021
Patent
MULTISPECIFIC FUSION PROTEIN AND USE THEREOF
PARK, Bum-Chan, LEE, Hyun Mi, PARK, Young Woo, SONG, Youngja, RYU, Jaenam, KIM, Yeungchul, BAEK, Gisun, KIM, Hye-Nan, BAK, Jeonghyeon, SONG, Jaeho, MOK, Jinkeol, LEE, Eunjin, JANG, Seil, LEE, Jaemin, KIM, Na Young, YANG, So-Young, JANG, Changho, YOON, Jaebong
Year of Publication 15.04.2021
Get full text
Year of Publication 15.04.2021
Patent
MULTISPECIFIC FUSION PROTEIN AND USE THEREOF
PARK Young Woo, SONG Jaeho, MOK Jinkeol, BAEK Gisun, KIM Na Young, KIM Hye- Nan, SONG Youngja, LEE Eunjin, YOON Jaebong, JANG Changho, LEE Jaemin, KIM Yeungchul, LEE Hyun Mi, JANG Seil, BAK Jeonghyeon, YANG So- Young, PARK Bum- Chan, RYU Jaenam
Year of Publication 19.07.2022
Get full text
Year of Publication 19.07.2022
Patent
PROTEÍNA DE FUSÃO MULTIESPECÍFICA, USO DA MESMA PARA TRATAR CÂNCER, MÉTODO PARA PRODUZIR A DITA PROTÉINA, COMPOSIÇÃO FARMACÊUTICA QUE COMPREENDE A DITA PROTEÍNA, POLINUCLEOTÍDEO, VETOR E CÉLULA TRANSFORMADA
JAEHO SONG, SO-YOUNG YANG, JEONGHYEON BAK, EUNJIN LEE, SEIL JANG, HYUN MI LEE, JINKEOL MOK, NA YOUNG KIM, YOUNGJA SONG, YEUNGCHUL KIM, JAEBONG YOON, BUMAN PARK, HYE-NAN KIM, GISUN BAEK, YOUNG WOO PARK, JAENAM RYU, CHANGHO JANG, JAEMIN LEE
Year of Publication 28.06.2022
Get full text
Year of Publication 28.06.2022
Patent